The most common type of thrombophilia was heterozygous FVL mutation (714 patients, 20%), followed by heterozygous prothrombin 20210G>A mutation (193 patients, 5%) and antiphospholipid antibody syndrome (119 patients, 3%) (Figure 2). Here, F2 is linked to antiphospholipid syndrome.